266 related articles for article (PubMed ID: 31130109)
1. Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse model.
Niu X; Zhao L; Qu L; Yao Z; Zhang F; Yan Q; Zhang S; Liang R; Chen P; Luo J; Xu W; Lv H; Liu X; Lei H; Yi C; Li P; Wang Q; Wang Y; Yu L; Zhang X; Bryan LA; Davidson E; Doranz JB; Feng L; Pan W; Zhang F; Chen L
Emerg Microbes Infect; 2019; 8(1):749-759. PubMed ID: 31130109
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal Antibodies against Zika Virus NS1 Protein Confer Protection via Fc
Yu L; Liu X; Ye X; Su W; Zhang X; Deng W; Luo J; Xiang M; Guo W; Zhang S; Xu W; Yan Q; Wang Q; Cui Y; Wu C; Guo W; Niu X; Zhang F; Lei C; Qu L; Chen L; Feng L
mBio; 2021 Feb; 12(1):. PubMed ID: 33563822
[TBL] [Abstract][Full Text] [Related]
3. Dengue virus envelope protein domain III-elicited antibodies mediate cross-protection against Zika virus in a mouse model.
Zhou Y; Chen D; Yang L; Zou W; Duan Z; Zhang Y; Wen J
Virus Res; 2020 Mar; 278():197882. PubMed ID: 31981774
[TBL] [Abstract][Full Text] [Related]
4. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
[TBL] [Abstract][Full Text] [Related]
5. Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy.
Tai W; Chen J; Zhao G; Geng Q; He L; Chen Y; Zhou Y; Li F; Du L
J Virol; 2019 Sep; 93(17):. PubMed ID: 31189716
[TBL] [Abstract][Full Text] [Related]
6. Rational Engineering and Characterization of an mAb that Neutralizes Zika Virus by Targeting a Mutationally Constrained Quaternary Epitope.
Tharakaraman K; Watanabe S; Chan KR; Huan J; Subramanian V; Chionh YH; Raguram A; Quinlan D; McBee M; Ong EZ; Gan ES; Tan HC; Tyagi A; Bhushan S; Lescar J; Vasudevan SG; Ooi EE; Sasisekharan R
Cell Host Microbe; 2018 May; 23(5):618-627.e6. PubMed ID: 29746833
[TBL] [Abstract][Full Text] [Related]
7. ZIKV Envelope Domain-Specific Antibodies: Production, Purification and Characterization.
Akhras S; Herrlein ML; Elgner F; Holzhauser T; Hildt E
Viruses; 2019 Aug; 11(8):. PubMed ID: 31412626
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of differential Zika and dengue virus neutralization by a public antibody lineage targeting the DIII lateral ridge.
Zhao H; Xu L; Bombardi R; Nargi R; Deng Z; Errico JM; Nelson CA; Dowd KA; Pierson TC; Crowe JE; Diamond MS; Fremont DH
J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31757867
[TBL] [Abstract][Full Text] [Related]
9. Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies.
Gallichotte EN; Young EF; Baric TJ; Yount BL; Metz SW; Begley MC; de Silva AM; Baric RS
mBio; 2019 Sep; 10(5):. PubMed ID: 31530669
[TBL] [Abstract][Full Text] [Related]
10. Neutralization of Zika virus by E protein domain III-Specific human monoclonal antibody.
Kim SI; Kim S; Shim JM; Lee HJ; Chang SY; Park S; Min JY; Park WB; Oh MD; Kim S; Chung J
Biochem Biophys Res Commun; 2021 Mar; 545():33-39. PubMed ID: 33535104
[TBL] [Abstract][Full Text] [Related]
11. Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III.
Wu Y; Li S; Du L; Wang C; Zou P; Hong B; Yuan M; Ren X; Tai W; Kong Y; Zhou C; Lu L; Zhou X; Jiang S; Ying T
Emerg Microbes Infect; 2017 Oct; 6(10):e89. PubMed ID: 29018252
[TBL] [Abstract][Full Text] [Related]
12. Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses.
Tai W; He L; Wang Y; Sun S; Zhao G; Luo C; Li P; Zhao H; Fremont DH; Li F; Jiang S; Zhou Y; Du L
Emerg Microbes Infect; 2018 Jan; 7(1):7. PubMed ID: 29362446
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope.
Long F; Doyle M; Fernandez E; Miller AS; Klose T; Sevvana M; Bryan A; Davidson E; Doranz BJ; Kuhn RJ; Diamond MS; Crowe JE; Rossmann MG
Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1591-1596. PubMed ID: 30642974
[TBL] [Abstract][Full Text] [Related]
14. Zika virus envelope nanoparticle antibodies protect mice without risk of disease enhancement.
Shukla R; Shanmugam RK; Ramasamy V; Arora U; Batra G; Acklin JA; Krammer F; Lim JK; Swaminathan S; Khanna N
EBioMedicine; 2020 Apr; 54():102738. PubMed ID: 32305868
[TBL] [Abstract][Full Text] [Related]
15. Large-scale analysis of B-cell epitopes of envelope: Implications for Zika vaccine and immunotherapeutic development.
Almansour I; Alfares R; Aljofi H
F1000Res; 2018; 7():1624. PubMed ID: 31316749
[No Abstract] [Full Text] [Related]
16. Yeast-produced subunit protein vaccine elicits broadly neutralizing antibodies that protect mice against Zika virus lethal infection.
Zhang W; Qu P; Li D; Zhang C; Liu Q; Zou G; Dupont-Rouzeyrol M; Lavillette D; Jin X; Yin F; Huang Z
Antiviral Res; 2019 Oct; 170():104578. PubMed ID: 31394119
[TBL] [Abstract][Full Text] [Related]
17. Human antibody response to Zika targets type-specific quaternary structure epitopes.
Collins MH; Tu HA; Gimblet-Ochieng C; Liou GA; Jadi RS; Metz SW; Thomas A; McElvany BD; Davidson E; Doranz BJ; Reyes Y; Bowman NM; Becker-Dreps S; Bucardo F; Lazear HM; Diehl SA; de Silva AM
JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996133
[TBL] [Abstract][Full Text] [Related]
18. Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function.
Tsuji I; Vang F; Dominguez D; Karwal L; Sanjali A; Livengood JA; Davidson E; Fouch ME; Doranz BJ; Das SC; Dean HJ
J Virol; 2022 Jun; 96(11):e0007122. PubMed ID: 35575481
[TBL] [Abstract][Full Text] [Related]
19. Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells.
Basu R; Zhai L; Contreras A; Tumban E
Vaccine; 2018 Feb; 36(10):1256-1264. PubMed ID: 29395533
[TBL] [Abstract][Full Text] [Related]
20. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection.
Stettler K; Beltramello M; Espinosa DA; Graham V; Cassotta A; Bianchi S; Vanzetta F; Minola A; Jaconi S; Mele F; Foglierini M; Pedotti M; Simonelli L; Dowall S; Atkinson B; Percivalle E; Simmons CP; Varani L; Blum J; Baldanti F; Cameroni E; Hewson R; Harris E; Lanzavecchia A; Sallusto F; Corti D
Science; 2016 Aug; 353(6301):823-6. PubMed ID: 27417494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
